Oliver Wyman

<p>Civica Rx is poised to broaden its impact on the drug manufacturing supply chain in 2023 with the opening of its first production plant. Civica’s president and CEO discusses the company’s business model and plans for the future in this podcast.</p>

Marcia Macphearson

Partner, Health & Life Sciences, Oliver Wyman

Ned McCoy

President and CEO, Civica Rx

Civica Rx is poised to broaden its impact on the drug manufacturing supply chain in 2023 with the opening of its first production plant. Civica’s president and CEO discusses the company’s business model and plans for the future in this podcast. 


Tackling Drug Shortages, High Prices

Blog

Health and Life Sciences Practice

The Oliver Wyman Health Podcast features conversations with leaders who are pioneering the transformation of the health market. Oliver Wyman’s Health & Life Sciences Practice is a leader in value-based, consumer-centric healthcare, and serves clients in the pharmaceutical, biotechnology, medical devices, provider, and payer sectors. Topics covered in this series include the business challenges of transforming healthcare from volume to value, consumer engagement, consumer experience, digital health, care delivery models, strategy, leadership, and organization.
Oliver Wyman is a global leader in management consulting that combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. Oliver Wyman is a wholly owned subsidiary of Marsh & McLennan Companies [NYSE: MMC].

Tackling Drug Shortages, High Prices

Today's Guest

Marcia Macphearson

Ned McCoy